Business

Health Catalyst Reports Fourth Quarter and Year End 2025 Results

SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025. “We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million,” said Ben Albert, CEO of Health Catalyst “In 2026, we are focused on the fu

articleHealth Catalyst, IncMarch 12, 202630/news/health-catalyst-reports-fourth-quarter-and-year-end-2025-results-1
Health Catalyst Reports Fourth Quarter and Year End 2025 Results

About this update from Health Catalyst, Inc

[{"type":"image","alt":"Health Catalyst, Inc.","displaySize":"","headline":null,"caption":"Health Catalyst, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":54,"url":"https://media.zenfs.com/en/globenewswire.com/b2d079326ef5701e0241ee231300fa53"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XTzb5vPERqYY4C12.YUEdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b2d079326ef5701e0241ee231300fa53","width":300,"height":54}},"lazy":false},{"type":"text","content":"SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025.","length":284,"tagName":"p"},{"type":"text","content":"“We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million,” said Ben Albert, CEO of Health Catalyst “In 2026, we are focused on the future and on positioning Health Catalyst for long‑term success. As I continue to assess the business, I see both meaningful opportunities and clear areas where we must improve. I am confident in the strengths that continue to differentiate this company. Our mission, our people, and our core capabilities, grounded in thousands of improvement projects and billions of dollars in validated impact, provide a solid foundation for delivering meaningful value to our clients and shareholders. My priority is to build on these strengths, address our challenges with clarity and discipline, and move the company forward with a renewed sense of focus and execution.”","length":873,"tagName":"p"},{"type":"text","content":"Financial Highlights for the Three and Twelve Months Ended December 31, 2025","length":76,"tagName":"p"},{"type":"text","content":"Key Financial Measures","length":22,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"padding-left:0;padding-right:0;vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"colspan":"7","style":"border-bottom:solid black 1pt;text-align:center;vertical-align:middle;padding-left:0;padding-right:0;vertical-align:bottom;","val":[{"type":"text","content":"Three Mo...

View stock analysis, news, and events for Health Catalyst, Inc

Health CatalystFinancial Measuresfinancial measuresconsolidated financial statementsGross profitGross ProfitIntangible assetsintangible assetsannual recurring revenueGross Margintotal revenueGross margin